GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Pharmagen Inc (OTCPK:PHRX) » Definitions » FCF Margin %

Pharmagen (Pharmagen) FCF Margin % : -1.06% (As of Mar. 2014)


View and export this data going back to 2011. Start your Free Trial

What is Pharmagen FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pharmagen's Free Cash Flow for the three months ended in Mar. 2014 was $-0.01 Mil. Pharmagen's Revenue for the three months ended in Mar. 2014 was $1.32 Mil. Therefore, Pharmagen's FCF Margin % for the quarter that ended in Mar. 2014 was -1.06%.

As of today, Pharmagen's current FCF Yield % is 0.00%.

The historical rank and industry rank for Pharmagen's FCF Margin % or its related term are showing as below:

PHRX' s FCF Margin % Range Over the Past 10 Years
Min: -13.31   Med: 0   Max: 0
Current: -13.31


PHRX's FCF Margin % is not ranked
in the Medical Distribution industry.
Industry Median: 1.2 vs PHRX: -13.31


Pharmagen FCF Margin % Historical Data

The historical data trend for Pharmagen's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagen FCF Margin % Chart

Pharmagen Annual Data
Trend Jun10 Jun11 Dec12 Dec13
FCF Margin %
- - -53.41 -15.56

Pharmagen Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.28 -38.97 -12.29 -5.85 -1.06

Competitive Comparison of Pharmagen's FCF Margin %

For the Medical Distribution subindustry, Pharmagen's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmagen's FCF Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmagen's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pharmagen's FCF Margin % falls into.



Pharmagen FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pharmagen's FCF Margin for the fiscal year that ended in Dec. 2013 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2013 )/Revenue (A: Dec. 2013 )
=-0.749/4.813
=-15.56 %

Pharmagen's FCF Margin for the quarter that ended in Mar. 2014 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2014 )/Revenue (Q: Mar. 2014 )
=-0.014/1.319
=-1.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmagen FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pharmagen's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmagen (Pharmagen) Business Description

Traded in Other Exchanges
N/A
Address
9337 Fraser Avenue, Silver Spring, MD, USA, 20910
Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products. In addition, it also owns and sells a specialized over-the-counter multivitamin product called Clotamin, which is designed for patients suffering from warfarin, a blood thinner that has a known interaction with the vitamin K present in standard over-the-counter multivitamins. Geographically, all the activities are functioned through the region of United States.
Executives
Russell Skibsted officer: Former Executive Vice Pres., other: Former Chief Financial Officer 15 TRANQUILITY PLACE, LADERA RANCH CA 92694

Pharmagen (Pharmagen) Headlines

No Headlines